‘(b) Applicability- This chapter shall apply to all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco and to any other tobacco products that the Secretary by regulation deems to be subject to this chapter.
I find it interesting that two members of the CTP participated on the panel. Apparently CTP thought there might be some crossover between the "innovative products" discussed in Sec. 918 (regulated by CDER) and the "modified risk tobacco products" (MRTPs) described in Sec. 911, regulated by the CTP.
‘(a) In General- The Secretary shall--
‘(1) at the request of the applicant, consider designating products for smoking cessation, including nicotine replacement products as fast track research and approval products within the meaning of section 506;
‘(2) consider approving the extended use of nicotine replacement products (such as nicotine patches, nicotine gum, and nicotine lozenges) for the treatment of tobacco dependence; and
‘(3) review and consider the evidence for additional indications for nicotine replacement products, such as for craving relief or relapse prevention.
Until now, the tobacco control industry has not entertained any method for smoking cessation other than "total abstinence from tobacco use." Items b and c in Sec. 918 and MRTPS (under Sec. 911) introduce a "tobacco harm reduction" concept into the mix.
‘(1) IN GENERAL- Not later than 3 years after the date of enactment of the Family Smoking Prevention and Tobacco Control Act, the Secretary, after consultation with recognized scientific, medical, and public health experts (including both Federal agencies and nongovernmental entities, the Institute of Medicine of the National Academy of Sciences, and the Society for Research on Nicotine and Tobacco), shall submit to the Congress a report that examines how best to regulate, promote, and encourage the development of innovative products and treatments (including nicotine-based and non-nicotine-based products and treatments) to better achieve, in a manner that best protects and promotes the public health--
‘(A) total abstinence from tobacco use;
‘(B) reductions in consumption of tobacco; and
‘(C) reductions in the harm associated with continued tobacco use